These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24919751)

  • 21. Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications.
    Lepedda AJ; De Muro P; Capobianco G; Formato M
    J Diabetes Complications; 2017 Jan; 31(1):149-155. PubMed ID: 27842978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Yoshioka T; Ogawa Y; Imamaki H; Kusakabe T; Ebihara K; Omata M; Satoh N; Sugawara A; Barasch J; Nakao K
    Kidney Int; 2009 Feb; 75(3):285-94. PubMed ID: 19148153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.
    Tramonti G; Kanwar YS
    Endocrine; 2013 Jun; 43(3):494-503. PubMed ID: 23086402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes.
    de Carvalho JA; Tatsch E; Hausen BS; Bollick YS; Moretto MB; Duarte T; Duarte MM; Londero SW; Premaor MO; Comim FV; Delanghe JR; Moresco RN
    Clin Biochem; 2016 Feb; 49(3):232-6. PubMed ID: 26519090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease.
    Zhou LT; Lv LL; Qiu S; Yin Q; Li ZL; Tang TT; Ni LH; Feng Y; Wang B; Ma KL; Liu BC
    J Transl Med; 2019 Feb; 17(1):59. PubMed ID: 30819181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy.
    Najafian B; Kim Y; Crosson JT; Mauer M
    J Am Soc Nephrol; 2003 Apr; 14(4):908-17. PubMed ID: 12660325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary platelet-derived growth factor-BB as an early marker of nephropathy in patients with type 2 diabetes: an Egyptian study.
    Bessa SS; Hussein TA; Morad MA; Amer AM
    Ren Fail; 2012; 34(6):670-5. PubMed ID: 22486214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary IgG4 and Smad1 Are Specific Biomarkers for Renal Structural and Functional Changes in Early Stages of Diabetic Nephropathy.
    Doi T; Moriya T; Fujita Y; Minagawa N; Usami M; Sasaki T; Abe H; Kishi S; Murakami T; Ouchi M; Ichien G; Yamamoto K; Ikeda H; Koezuka Y; Takamatsu N; Shima K; Mauer M; Nagai K; Tominaga T
    Diabetes; 2018 May; 67(5):986-993. PubMed ID: 29490904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of fully automated and ultrasensitive assays for urinary adiponectin and their application as novel biomarkers for diabetic kidney disease.
    Watanabe T; Fujimoto Y; Morimoto A; Nishiyama M; Kawai A; Okada S; Aiba M; Kawano T; Kawahigashi M; Ishizu M; Mori H; Matsuhisa M; Hata A; Funaki M; Hashida S
    Sci Rep; 2020 Sep; 10(1):15869. PubMed ID: 32985540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated N-acetyl-β-d-glucosaminidase, a urinary tubular damage marker, is a significant predictor of carotid artery atherosclerosis in type 1 diabetes, independent of albuminuria: A cross-sectional study.
    Lee M; Hong N; Lee YH; Kang ES; Cha BS; Lee BW
    J Diabetes Complications; 2018 Aug; 32(8):777-783. PubMed ID: 29980431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes.
    Tonkonogi A; Carlsson AC; Helmersson-Karlqvist J; Larsson A; Ärnlöv J
    Ups J Med Sci; 2016 Aug; 121(3):174-8. PubMed ID: 27321055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel urinary biomarkers in pre-diabetic nephropathy.
    Garg V; Kumar M; Mahapatra HS; Chitkara A; Gadpayle AK; Sekhar V
    Clin Exp Nephrol; 2015 Oct; 19(5):895-900. PubMed ID: 25634253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.
    Wang M; Xie R; Liu R; Jia X; Bao Y; Liu X
    Endocrine; 2012 Oct; 42(2):329-34. PubMed ID: 22396142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis.
    Ioannou K
    Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing urinary levels of IL-18, NGAL and albumin creatinine ratio in patients with diabetic nephropathy.
    Sueud T; Hadi NR; Abdulameer R; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2019; 13(1):564-568. PubMed ID: 30641767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
    Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
    Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.